(Q42603615)

English

Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trial

scientific article published on June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 November 2017

Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trial (English)

1 reference

Europe PubMed Central

3 November 2017

gram-positive bacteria

0 references

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Horacio López

1

1 reference

Europe PubMed Central

3 November 2017

Jim Z Li

2

1 reference

Europe PubMed Central

3 November 2017

Dan A Balan

3

1 reference

Europe PubMed Central

3 November 2017

Richard J Willke

4

1 reference

Europe PubMed Central

3 November 2017

Brian E Rittenhouse

5

1 reference

Europe PubMed Central

3 November 2017

Essy Mozaffari

6

1 reference

Europe PubMed Central

3 November 2017

Gabriela Vidal

7

1 reference

Europe PubMed Central

3 November 2017

Teresa Zitto

8

1 reference

Europe PubMed Central

3 November 2017

Tom Tang

9

1 reference

Europe PubMed Central

3 November 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

3 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

3 November 2017

25

1 reference

Europe PubMed Central

3 November 2017

6

1 reference

Europe PubMed Central

3 November 2017

1846-1871

1 reference

Europe PubMed Central

3 November 2017

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nosocomial infection update

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance in intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vancomycin-resistant Staphylococcus aureus: apocalypse now?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vancomycin-resistant Staphylococcus aureus: infection control considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

New resistance in Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The comparative efficacy and safety of teicoplanin and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Current perspectives on glycopeptide resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to vancomycin and teicoplanin: an emerging clinical problem

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Linezolid: a review of its use in the management of serious gram-positive infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing antiinfective therapy of community-acquired pneumonia in the hospital setting: focus on switch therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous-to-oral antibiotic switch therapy. A cost-effective approach

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Resource costing for multinational neurologic clinical trials: methods and results.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of resistance in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic cycling and marketing into the 21st century: a perspective from the pharmaceutical industry

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential antibiotic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential antibiotic therapy: the right patient, the right time and the right outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential switch therapy for lower respiratory tract infections: a European perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980173-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80173-X

1 reference

Europe PubMed Central

3 November 2017

1 reference

Europe PubMed Central

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42603615&oldid=1962586317"